What happened to the prediction of 12-16 weeks since submission, CE mark will be achieved??? It must be week 20+ now.
What sort of time frame are we looking at here?
If the product even marginally improves outcomes for pancreatic cancer patients (which it has shown), shouldn't we expect CE to be granted rather quickly? How does this sort of thing work....
- Forums
- ASX - By Stock
- OSL
- Ann: Appendix 3B
OSL
oncosil medical ltd
Add to My Watchlist
2.00%
!
$1.02

Ann: Appendix 3B, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 99.5¢ | $44.55K | 44.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 192 | $1.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.04 | 6234 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 192 | 1.025 |
1 | 550 | 1.020 |
1 | 2993 | 1.000 |
1 | 3000 | 0.990 |
1 | 1000 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.040 | 6234 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.090 | 375 | 1 |
1.190 | 3563 | 1 |
Last trade - 15.48pm 25/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |